Form 4: Oscar Health CAO Baltrus Acquires RSUs, Sells Shares for Tax

Sentiment:

Insider Transaction Report


Oscar Health's Chief Accounting Officer, Victoria Baltrus, acquired restricted stock units and sold a portion of shares to cover tax obligations.

Summary

  • Victoria Baltrus, Chief Accounting Officer of Oscar Health, Inc. (OSCR), acquired 17,300 shares of Class A Common Stock in the form of restricted stock units (RSUs).
  • These RSUs will vest quarterly in 12 equal installments, commencing on June 1, 2026, contingent on her continuous service.
  • Baltrus also disposed of 4,638 shares of Class A Common Stock at a weighted average price of $13.39 per share, with individual transactions ranging from $13.00 to $13.85.
  • The sale was executed under a Rule 10b5-1 plan established on August 8, 2025, specifically to cover tax withholding obligations arising from the vesting of prior equity awards.
  • Following these transactions, Baltrus directly beneficially owns 216,112 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The acquisition of RSUs is a positive for executive retention, while the sale for tax withholding is a routine, non-discretionary transaction that does not indicate a change in sentiment towards the company.

Positives

  • Acquisition of 17,300 restricted stock units (RSUs) indicates continued equity incentive for the Chief Accounting Officer.
  • The vesting schedule for the RSUs, beginning June 1, 2026, and continuing quarterly for 12 installments, aligns the officer's interests with long-term company performance.

Negatives

  • The sale of 4,638 shares, although for tax withholding purposes, represents a reduction in direct beneficial ownership by the Chief Accounting Officer.

Future Outlook

The acquired restricted stock units will vest quarterly in 12 equal installments beginning on June 1, 2026, subject to the reporting person's continuous service, indicating a long-term incentive structure.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as the acquisition of equity awards and subsequent sales for tax purposes, are common occurrences across all industries and typically do not reflect specific industry trends or competitive positioning.

Stakeholder Impact

  • Shareholders: Minimal direct impact. The sale for tax purposes is routine and does not signal a change in company fundamentals or management's long-term view. The RSU grant aligns management's interests with shareholders.
  • Employees: No direct impact mentioned.
  • Customers: No direct impact mentioned.
  • Suppliers: No direct impact mentioned.
  • Creditors: No direct impact mentioned.

Next Steps

  • The acquired restricted stock units will begin vesting quarterly in 12 equal installments starting June 1, 2026.

Key Dates

DateDescription
2025-08-08Date Rule 10b5-1 instruction letter was entered into for the sale of shares.
2026-03-02Date of earliest transaction, including acquisition of RSUs and sale of shares.
2026-03-04Date the Form 4 was signed by the attorney-in-fact.
2026-06-01First vesting date for the acquired restricted stock units.

Recommendation

hold

This Form 4 filing details routine insider transactions, specifically the grant of restricted stock units and a sale of shares to cover tax obligations. These are standard events for executives and do not provide new fundamental information that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing does not present new catalysts for significant price movement.

Keywords

Oscar Health, OSCR, Victoria Baltrus, Chief Accounting Officer, Form 4, Insider Trading, Restricted Stock Units, RSU, Equity Compensation, Tax Withholding, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.